Medeon Biodesign, Inc. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was TWD 137.020 million compared to TWD 94.592 million a year ago. Operating loss was TWD 42.597 million compared to TWD 60.643 million a year ago. Net loss was TWD 53.502 million compared to TWD 52.724 million a year ago. Basic loss per share was TWD 0.8 compared to TWD 0.82 a year ago.